This plot summarizes the available laboratory evidence on the ability of COVID-19 vaccines to neutralize SARS-CoV-2 variants of concern.

This table summarizes the vaccine effectiveness data for COVID-19 studies conducted globally. This table is updated weekly. 

This file contains a list of neutralization studies identified from an ongoing systematic review of literature evaluating the impact of SARS-CoV 2 variants of concern on COVID-19 vaccine performance. 

These forest plots summarize available COVID-19 vaccine effectiveness data by vaccine and variant of concern. These forest plots are updated weekly. 

The COVID-19 Maternal Immunization Tracker (COMIT) provides a global snapshot of public health polic

This document outlines the methods used in the COVID-19 vaccines effectiveness and impact studies review. 

The VIEW-hub report displays data and figures on the introduction, use, and coverage status of typhoid conjugate, human papillomavirus, pneumococcal, rotavirus, Haemophilus influenzae type b, and inactivated polio vaccines both globally and in the

The VIEW-hub report displays data and figures on the introduction, use, and coverage status of typhoid conjugate, human papillomavirus, pneumococcal, rotavirus, Haemophilus influenzae type b, and inactivated polio vaccines both globally and in the

The VIEW-hub report displays data and figures on the introduction, use, and coverage status of human papillomavirus, pneumococcal, rotavirus, Haemophilus influenzae type b, and inactivated polio vaccines both globally and in the 73 Gavi countries

The VIEW-hub report displays data and figures on the introduction, use, and coverage status of pneumococcal, rotavirus, and inactivated polio vaccines both globally and in the 73 Gavi countries as of September 2020.